Abstract
Silicon nanochannel field effect transistor (FET) biosensors are one of the most promising technologies in the development of highly sensitive and label-free analyte detection for cancer diagnostics. With their exceptional electrical properties and small dimensions, silicon nanochannels are ideally suited for extraordinarily high sensitivity. In fact, the high surface-to-volume ratios of these systems make single molecule detection possible. Further, FET biosensors offer the benefits of high speed, low cost, and high yield manufacturing, without sacrificing the sensitivity typical for traditional optical methods in diagnostics. Top down manufacturing methods leverage advantages in Complementary Metal Oxide Semiconductor (CMOS) technologies, making richly multiplexed sensor arrays a reality. Here, we discuss the fabrication and use of silicon nanochannel FET devices as biosensors for breast cancer diagnosis and monitoring.
Introduction
Traditional cancer diagnostics often rely on optical biosensing methods like fluorescence or luminescence, which necessitate bulky instrumentation and complex "labeling" protocols. Furthermore, breast cancer is a heterogeneous disease; a single biomarker is rarely sufficient for a complete diagnosis. There is a critical need for "fingerprinting" tumors using multiple biomarkers simultaneously.
The authors address the gap between high-sensitivity laboratory techniques and the need for portable, low-cost, and rapid diagnostic tools. They propose that silicon nanochannel FETs can overcome these hurdles by providing electronic, label-free detection with a high surface-to-volume ratio that enables extreme sensitivity.
Methods and Fabrication
The researchers utilized a top-down fabrication approach, which is more scalable and reproducible than traditional bottom-up nanowire growth. Using Silicon-On-Insulator (SOI) wafers, they employed photolithography and electron-beam lithography to define the nanochannels. Reactive Ion Etching (RIE) provided vertical relief, and Atomic Layer Deposition (ALD) was used to coat the wires with a thin layer of $Al_2O_3$ for insulation.
To make the sensors specific, the surface was treated with APTES to create an aldehyde-terminated surface, followed by the conjugation of specific antibodies (such as monoclonal CA15.3) using EDC/sulfo-NHS crosslinking chemistry. The device acts as a transistor where the "gate" is the biological binding event. When a charged protein binds to the antibody on the nanowire, it creates an electric field that changes the conductance ($G$) of the silicon channel.
Key Results
The sensor was validated using the CA15.3 tumor antigen, a well-known epithelial marker overexpressed in breast and ovarian cancers. Key performance metrics included:
- High Sensitivity: The sensor detected CA15.3 at concentrations as low as 7.7 U/ml (~60 pM).
- Rapid Response: Stable readings were achieved in less than 60 seconds, significantly faster than traditional lab-based assays.
- Wide Dynamic Range: The sensor showed a linear response over three orders of magnitude, covering the clinically relevant range for monitoring cancer progression.
- Specificity: The device showed no detectable conductance change when exposed to high concentrations of non-target proteins, proving the effectiveness of the surface passivation.
Discussion and Future Outlook
A critical insight of this work is the dominance of surface-to-volume ratios at the nanoscale; a single binding event can perturb the electrical properties of the entire channel. Furthermore, by adjusting the gate voltage to the subthreshold region, the authors could amplify the sensor's sensitivity by at least an order of magnitude.
While current sensitivity is excellent, the authors aim to reach a 1000-fold increase over standard techniques in future iterations. The next major step is building multiplexed arrays that detect multiple markers simultaneously on a single chip to improve diagnostic accuracy. Moving the technology from a laboratory setup to a handheld, user-friendly point-of-care device remains the primary engineering challenge.
Summary updated